Revista nº 22

ALSUntangled No. 22: Propofol.

ISSN 2167-8421 print/ISSN 2167-9223 online © 2013 Informa Healthcare DOI: 10.3109/21678421.2013.826469 neuroinfl ammation (18,19) occur in ALS, although attempts to manipulate these events have not yet shown clear benefi ts in human ALS trials. Propofol has a short half-life; once infusion is stopped, its clinical effects last only minutes (3). For this reason, it is diffi cult to understand ho...

Correction: Vol. 22, No. 8

Author affiliations: University of Helsinki, Helsinki, Finland (M. Meriluoto, L. Hedman, M. Knip, K. Hedman, M. Söderlund-Venermo); Helsinki University Central Hospital, Helsinki (L. Hedman, M. Knip, K. Hedman); University of Turku, Turku, Finland (L. Tanner, V. Simell, M. Mäkinen, S. Simell, J. Mykkänen, J. Korpelainen, O. Ruuskanen, J. Ilonen, O. Simell); University of Eastern Finland, Kuopio...

Correction: Vol. 22, No. 1

Correction: Vol. 22, No. 7

Gulf Coast are refractory to Zika virus infection. The Zika virus strains and actual stocks used for our experiments were infectious for Ae. aegypti mosquitoes in other experiments (C. Roundy et al., unpub. data), indicating that our negative findings for Cx. quinquefasciatus and Ae. taeniorhynchus mosquitoes represent truly refractory phenotypes. These results, along with findings from an outb...

Correction: Vol. 22, No. 6